Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR181A1 host gene (MIR181A1HG) is a long non-coding RNA gene located on chromosome 1. It is part of the regulatory network involving microRNA precursors, specifically mir-181, and is implicated in the control of multiple cellular processes including cell proliferation, cell death, extracellular matrix organization, bone development, and signaling pathways such as ERK and MAPK. MIR181A1HG has been associated with acute myeloid leukemia and other hematologic malignancies. Knockdown studies indicate that MIR181A1HG modulates the expression of hundreds of protein-coding genes involved in these biological pathways, suggesting a role in cancer biology and possibly serving as a biomarker for disease[3][9][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR181A1 host gene (MIR181A1HG).